Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment
Wall Street Journal
Lilly’s Kisunla was shown in a study to slow the decline of Alzheimer’s patients.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Lilly’s Kisunla was shown in a study to slow the decline of Alzheimer’s patients.